Comparison of the RECIST and PERCIST criteria in solid tumors: a pooled analysis and review
Authors:
Open Access
- 28 March 2016
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (19) , 27848-27854
Abstract
Comparison of the RECIST and PERCIST criteria in solid tumors: a pooled analysis and reviewKeywords
This publication has 24 references indexed in Scilit:
- Correlation between early 18F-FDG PET/CT response to BRAF and MEK inhibition and survival in patients with BRAF-mutant metastatic melanomaNuclear Medicine Communications, 2016
- Prognostic impact of initial maximum standardized uptake value of 18F-FDG PET/CT on treatment response in patients with metastatic lung adenocarcinoma treated with erlotinibOncoTargets and Therapy, 2015
- The role of response evaluation criteria in solid tumour in anticancer treatment evaluation: Results of a survey in the oncology communityEuropean Journal of Cancer, 2014
- Early FDG/PET Scanning as a Pharmacodynamic Marker of Anti-EGFR Antibody Activity in Colorectal CancerMolecular Cancer Therapeutics, 2012
- From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid TumorsJournal of Nuclear Medicine, 2009
- Considerations for the Use of Imaging Tools for Phase II Treatment Trials in OncologyClinical Cancer Research, 2009
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Individual patient data analysis to assess modifications to the RECIST criteriaEuropean Journal of Cancer, 2009
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI: Journal of the National Cancer Institute, 2000
- Reporting results of cancer treatmentCancer, 1981